SEC Filings for Ayala Pharmaceuticals, Inc.
DEF 14A - Other definitive proxy statements
Form Type: DEF 14A
Filing Date: 2022-02-28
View Filing
10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Form Type: 10-K
Filing Date: 2022-02-14
View Filing
D - Notice of Exempt Offering of Securities
Form Type: D
Filing Date: 2022-02-11
View Filing
SC 13G/A [Amend] - Statement of Beneficial Ownership by Certain Investors
Form Type: SC 13G/A
Filing Date: 2022-02-10
View Filing
25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
Form Type: 25-NSE
Filing Date: 2022-02-09
View Filing
PRE 14A - Other preliminary proxy statements
Form Type: PRE 14A
Filing Date: 2022-02-04
View Filing
8-K - Current report
Form Type: 8-K
Filing Date: 2022-02-01
View Filing
NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405
Form Type: NT 10-K
Filing Date: 2022-01-31
View Filing
8-K - Current report
Form Type: 8-K
Filing Date: 2022-01-28
View Filing
8-K - Current report
Form Type: 8-K
Filing Date: 2021-12-30
View Filing
